HSBC Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-93,256
| Closed | -$296K | – | 2685 |
|
|
2020
Q3 | $296K | Sell |
93,256
-5,378
| -5% | -$17.1K | ﹤0.01% | 1852 |
|
|
2020
Q2 | $287K | Buy |
+98,634
| New | +$287K | ﹤0.01% | 1787 |
|
|
2020
Q1 | – | Sell |
-13,072
| Closed | -$43K | – | 2558 |
|
|
2019
Q4 | $43K | Buy |
13,072
+616
| +5% | +$2.03K | ﹤0.01% | 2417 |
|
|
2019
Q3 | $27K | Buy |
+12,456
| New | +$27K | ﹤0.01% | 2425 |
|
|
2019
Q2 | – | Sell |
-10,175
| Closed | -$38K | – | 2288 |
|
|
2019
Q1 | $38K | Buy |
+10,175
| New | +$38K | ﹤0.01% | 2115 |
|
|
2017
Q2 | – | Sell |
-223,634
| Closed | -$520K | – | 1810 |
|
|
2017
Q1 | $520K | Sell |
223,634
-27,057
| -11% | -$62.9K | ﹤0.01% | 1223 |
|
|
2016
Q4 | $531K | Buy |
250,691
+27,860
| +13% | +$59K | ﹤0.01% | 1373 |
|
|
2016
Q3 | $745K | Hold |
222,831
| – | – | ﹤0.01% | 1077 |
|
|
2016
Q2 | $700K | Buy |
222,831
+1,716
| +0.8% | +$5.39K | ﹤0.01% | 1086 |
|
|
2016
Q1 | $737K | Buy |
221,115
+553
| +0.3% | +$1.84K | ﹤0.01% | 1104 |
|
|
2015
Q4 | $786K | Sell |
220,562
-4,016
| -2% | -$14.3K | ﹤0.01% | 1114 |
|
|
2015
Q3 | $1.13M | Sell |
224,578
-168,154
| -43% | -$848K | ﹤0.01% | 1046 |
|
|
2015
Q2 | $2.54M | Buy |
392,732
+99,956
| +34% | +$646K | 0.01% | 895 |
|
|
2015
Q1 | $2.06M | Buy |
+292,776
| New | +$2.06M | ﹤0.01% | 945 |
|